Delayed Cardiac Metastasis from Renal Cell Carcinoma Caused by VHL Mutation

Main Article Content

Christopher L. Sudduth
Anthony Castagno
Peter Maggs


cardiac, metastatic, mutation, renal cell carcinoma, VHL


Cardiac metastasis caused by renal cell carcinoma (RCC) without vena caval involvement is rare. No mutation has been associated with this unique phenotype. A 77-year-old male presented to our clinic with a symptomatic right ventricular mass after nephrectomy for clear cell RCC (ccRCC). The mass was resected, and metastatic disease was confirmed. Targeted exon sequencing identified a VHL mutation (c.494T > G, p.V165G) in the resected specimen. While more than half of ccRCC cases are associated with VHL mutations, this case is the first to show the association between delayed, isolated cardiac metastasis and VHL V165G mutation. The phenotype presented 12 years after nephrectomy and localized to the right ventricular apex. Further genomic characterization of cases with cardiac metastases may provide clues regarding unique mutations noted. Patients exhibiting delayed spread of RCC to the heart must be screened for this mutation.

Abstract 225 | PDF Downloads 362 HTML Downloads 30 XML Downloads 8


1. Aburto J, Bruckner BA, Blackmon SH, Beyer EA, Reardon MJ. Renal cell carcinoma, metastatic to the left ventricle. Texas Heart Inst J. 2009;36(1):48.

2. Viteri Malone MA, Ares GR, De Velasco G, Brandão R, Lin X, Norton C, et al. The clinical presentation, survival outcomes, and management of patients with renal cell carcinoma and cardiac metastasis without inferior vena cava involvement: Results from a pooled clinical trial database and systematic review of reported cases. Clin Genitourin Cancer. 2018;16(2):e327–33. 10.1016/j.clgc.2017.11.005

3. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet. 1994;7(1):85–90. 10.1038/ng0594-8

4. Brugarolas J. Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol. 2014;32(18):1968–76. 10.1200/JCO.2012.45.2003

5. Shirotake S, Umezawa Y, Okabe T, Kaneko G, Kanao K, Nishimoto K, et al. Efficacy of nivolumab plus ipilimumab in a patient with renal cell carcinoma concomitant with cardiac metastasis: A case report. In Vivo. 2020;34(3):1475–80. 10.21873/invivo.11932

6. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7. 10.1038/nature11252

7. Kibel A, Iliopoulos O, DeCaprio JA, Kaelin WG. Binding of the von Hippel–Lindau tumor suppressor protein to Elongin B and C. Science. 1995;269(5229):1444–6. 10.1126/science.7660130

8. Bradley JF, Collins DL, Schimke RN, Parrott HN, Rothberg PG. Two distinct phenotypes caused by two different missense mutations in the same codon of the VHL gene. J Med Genet. 1999;87(2):163–7. 10.1002/(sici)1096-8628(19991119)87:2<163::aid-ajmg7>;2-a

9. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. 10.1038/nrdp.2017.9

10. Talukder MQ, Deo S V., Maleszewski JJ, Park SJ. Late isolated metastasis of renal cell carcinoma in the left ventricular myocardium. Interact Cardiovasc Thorac Surg. 2010;11(6):814–6. 10.1510/icvts.2010.246223

11. Zhang B, Malouf J, Young P, Kohli M, Dronca R. Cardiac metastasis in renal cell carcinoma without vena cava or atrial involvement: An unusual presentation of metastatic disease. Rare Tumors. 2013;5(3):e29. 10.4081/rt.2013.e29